Celanese Corp. (CE) Tops Q2 EPS by 21c; offers guidance
Get Alerts CE Hot Sheet
Price: $44.67 -1.17%
EPS Growth %: +20.9%
Financial Fact:
Earnings (loss) from continuing operations: 265M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +20.9%
Financial Fact:
Earnings (loss) from continuing operations: 265M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Celanese Corp. (NYSE: CE) reported Q2 EPS of $2.45, $0.21 better than the analyst estimate of $2.24. Revenue for the quarter came in at $2.75 billion versus the consensus estimate of $2.76 billion.
GUIDANCE:
Celanese Corp. sees Q3 2026 EPS of $1.35-$1.75, versus the consensus of $1.77.
Celanese Corp. sees FY2026 EPS of $6.00, versus the consensus of $6.05.
For earnings history and earnings-related data on Celanese Corp. (CE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- FDA grants accelerated approval to AstraZeneca's camizestrant combo
- Computacenter Plc. (CCC:LN) PT Raised to GBP60 at JPMorgan
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share